Related Experiment Video
Updated: Aug 9, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Cholestatic disorders of infancy
1Indiana University School of Medicine, Indianapolis, Indiana.
Insights
Persistent cholestasis in infants requires prompt diagnosis and treatment, moving beyond watchful waiting. Advances in surgery and nutrition offer new hope, including liver transplantation for biliary atresia.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Neonatal Medicine
Background:
- Persistent cholestasis in infants necessitates a shift from passive observation to active diagnostic and therapeutic approaches.
- Neonatal hepatitis and biliary atresia are key conditions requiring timely intervention.
- Surgical and nutritional advancements have significantly altered management paradigms.
Purpose of the Study:
- To review current strategies for managing infants with persistent cholestasis.
- To highlight the importance of identifying the etiology of neonatal hepatitis for targeted treatment.
- To discuss the role of improved surgical techniques and nutritional support in treating biliary atresia and its complications.
Main Methods:
- Review of recent advancements in the diagnosis and treatment of neonatal cholestasis.
- Analysis of surgical outcomes for portoenterostomy in biliary atresia.
- Evaluation of evolving nutritional strategies and the role of liver transplantation.
Main Results:
- Early etiological diagnosis of neonatal hepatitis enables specific treatments.
- Enhanced surgical techniques for portoenterostomy improve outcomes for biliary atresia.
- Advanced nutritional support and liver transplantation offer viable options for treatment failures.
Conclusions:
- The management of persistent infant cholestasis has evolved from a 'wait and see' approach to proactive diagnosis and intervention.
- Improved surgical and nutritional strategies, including liver transplantation, have expanded treatment options for conditions like biliary atresia.
- Continued research and collaboration among investigators are crucial for advancing infant liver disease care.
Abstract:
We no longer view the infant with persistent cholestasis with a "wait and see" strategy. Identification of the cause of "neonatal hepatitis" may allow specific treatment. Improved surgical techniques for portoenterostomy have provided early hope for patients with biliary atresia. Rapidly advancing nutritional strategies allow many portoenterostomy failures an additional further option, that is, hepatic transplantation. I express my thanks to the many investigators who have contributed and are continuing to advance the progress recounted in this review. Perusal of the references cited in this review makes clear the identity of these investigators.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Jaundice
Cholecystitis
Chronic Pancreatitis I: Introduction

